デフォルト表紙
市場調査レポート
商品コード
1427843

ヘルスケアCROサービスの世界市場レポート 2024年

Healthcare CRO Services Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘルスケアCROサービスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアCROサービスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.6%の年間複合成長率(CAGR)で857億3,000万米ドルに成長すると予想されています。予測期間中に予想される成長は、生物製剤および細胞および遺伝子治療の台頭、希少疾患への注目の高まり、費用対効果とスピードの重視、現実世界のデータに対する需要の増大、患者への焦点の当てによるものと考えられます。中心性とバイオ医薬品パイプラインの成長があります。予測期間の主な動向には、人工知能(AI)の統合、機械学習(ML)の組み込み、環境、社会、ガバナンス(ESG)要素の考慮、製薬会社による研究開発(R&D)投資の拡大が含まれます。企業。

ヘルスケアCROサービス市場の予想される成長は、ヘルスケア費の増加によって促進されると予想されます。ヘルスケア費には、健康に重点を置いた医療サービス、家族計画活動、栄養プログラム、緊急援助の提供に関連するすべての費用が含まれます。ヘルスケア支出の増加は、ヘルスケアCROサービスと臨床試験や研究をサポートする役割の需要の高まりとともに、医療研究開発のための資金プールの拡大に貢献しています。たとえば、米国の連邦機関であるメディケア・メディケイド・サービスセンターによると、2023年2月の時点で、同国は2021年に4兆3,000億米ドル(国民1人当たり1万2,914米ドルに相当)をヘルスケアに費やしました。これは前年比2.7%の増加を反映しており、ヘルスケア支出は国のGDPの18.3%を占めています。したがって、ヘルスケア費の急増がヘルスケアCROサービス市場の成長の原動力となっています。

臨床試験の数の増加により、ヘルスケアCROサービス市場の成長がさらに促進されることが予想されます。臨床試験は、薬物、治療法、機器、手順などの新しい医療介入の安全性と有効性を評価するために設計された、人間の参加者が参加する科学的研究です。受託調査機関(CRO)は、製薬企業やバイオテクノロジー企業による研究の効率的な設計、実施、管理を支援するさまざまなサービスを提供することで、臨床試験プロセスにおいて重要な役割を果たしています。たとえば、カナダを拠点とするウェブニュースおよび情報ネットワークであるXtalksのレポートによると、2023年 5月の時点でClinicalTrials.govに登録されている臨床研究は452,604件あり、2021年初頭に記録された365,000件を超える登録臨床試験から大幅に増加しています。したがって、臨床試験の増加はヘルスケアCROサービス市場の拡大に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のヘルスケアCROサービス市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のヘルスケアCROサービス市場の規模実績と成長、2018年~2023年
  • 世界のヘルスケアCROサービス市場の規模と成長予測、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のヘルスケアCROサービス市場、サービスタイプ別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 初期段階の開発
  • 臨床開発サービス
  • 検査サービス
  • コンサルティングサービス
  • 世界のヘルスケアCROサービス市場、治療領域別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 腫瘍学
  • 中枢神経系疾患
  • 循環器疾患
  • 代謝性疾患
  • 感染症
  • 糖尿病
  • その他の治療領域
  • 世界のヘルスケアCROサービス市場、エンドユーザー別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 製薬会社
  • 医療機器企業
  • 学術機関

第7章 地域および国の分析

  • 世界のヘルスケアCROサービス市場、地域別、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 世界のヘルスケアCROサービス市場、国別、実績および予測、2018年~2023年、2023年~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ヘルスケアCROサービス市場の競合情勢
  • ヘルスケアCROサービス市場の企業プロファイル
    • Laboratory Corporation of America Holdings.
    • IQVIA Inc.
    • Icon Plc.
    • PPD Inc.
    • Wuxi Apptec Co. Ltd.

第31章 その他の大手・革新的企業

  • Syneos Health Inc.
  • Parexel International Corporation
  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Medpace Inc.
  • Pharmaron Beijing Co. Ltd.
  • BioClinica Inc.
  • Chiltern International Ltd.
  • Evotec SE
  • PSI CRO AG
  • Premier Research Group Ltd.
  • Worldwide Clinical Trials Inc.
  • Caidya
  • BioTelemetry Inc.
  • Syngene International Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13687

Healthcare Contract Research Organization (CRO) services encompass the outsourced support and specialized expertise provided to the pharmaceutical, biotechnology, and medical device sectors by dedicated businesses. These entities seek assistance from contract research organizations for a range of research-related tasks, including data management, conducting clinical trials, and preparing regulatory submissions.

The primary categories of healthcare CRO services include early-phase development, clinical development services, laboratory services, and consulting services. Early-phase development denotes the initial stage of a project or enterprise, involving the investigation, testing, and validation of theories or hypotheses to establish the foundation for future development and progress. These services find application in various therapeutic areas such as oncology, CNS disorders, cardiovascular diseases, metabolic diseases, infectious diseases, diabetes, and others. Multiple end-users, including pharmaceutical companies, medical device companies, and academic institutes, engage in the utilization of these services.

The healthcare CRO services market research report is one of a series of new reports from The Business Research Company that provides healthcare CRO services market statistics, including healthcare CRO services industry global market size, regional shares, competitors with a healthcare CRO services market share, detailed healthcare CRO services market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare CRO services industry. This healthcare CRO services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare cro services market size has grown strongly in recent years. It will grow from $56.8 billion in 2023 to $61.61 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth witnessed in the historical period can be ascribed to the heightened emphasis on regulatory and medical affairs services provided by CROs, the globalization of clinical trials, the escalating complexity of clinical trials, the digital transformation in clinical trials, and the rising prevalence of chronic diseases.

The healthcare cro services market size is expected to see strong growth in the next few years. It will grow to $85.73 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to the ascent of biologics and cell and gene therapies, a heightened focus on rare diseases, emphasis on cost-effectiveness and speed, an increasing demand for real-world data, a focus on patient-centricity, and the growth of the biopharmaceutical pipeline. Major trends in the forecast period include the integration of artificial intelligence (AI), incorporation of machine learning (ML), considerations of environmental, social, and governance (ESG) factors, and the escalation of research and development (R&D) investments by pharmaceutical companies.

The anticipated growth in the healthcare CRO services market is expected to be propelled by the increase in healthcare expenditures. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency aid with a focus on health. The rise in healthcare spending, along with the growing demand for healthcare CRO services and their role in supporting clinical trials and studies, contributes to a larger pool of financing for medical research and development. For instance, as of February 2023, according to the Centers for Medicare and Medicaid Services, a federal agency in the United States, the country spent $4.3 trillion in 2021, equivalent to $12,914 per person, on healthcare. This reflected a 2.7% increase from the previous year, and healthcare spending accounted for 18.3% of the nation's GDP. Therefore, the upsurge in healthcare expenditures is a driving force behind the growth of the healthcare CRO services market.

The increasing number of clinical trials is expected to further boost the growth of the healthcare CRO services market. Clinical trials are scientific studies involving human participants designed to assess the safety and effectiveness of new medical interventions, such as drugs, therapies, devices, or procedures. Contract research organizations (CROs) play a vital role in the clinical trial process by providing various services that assist pharmaceutical and biotechnology companies in designing, conducting, and managing their studies efficiently. For instance, according to a report from Xtalks, a Canada-based web news and information network, there were 452,604 clinical studies registered on ClinicalTrials.gov as of May 2023, representing a significant increase from the over 365,000 registered trials recorded in early 2021. Therefore, the growth in clinical trials is contributing to the expansion of the healthcare CRO services market.

Major players in the healthcare CRO services market are adopting a strategic partnership approach to provide advanced Proteomics CRO services to biopharmaceutical and biomarker clients on a global scale. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. In January 2023, Bruker Corporation, a US-based manufacturer of scientific instruments, formed a partnership with Biognosys AG, a Switzerland-based healthcare CRO services provider. The collaboration between Bruker and Biognosys is expected to create unique synergies, combining Biognosys' extensive range of proprietary proteomics services, software, and kits with Bruker's innovative timsTOF platform. This strategic partnership will result in the establishment of Biognosys' inaugural laboratory for advanced proteomics CRO services in the United States.

Major companies in the healthcare CRO services market are also innovating by developing products such as clinical trial monitoring solutions to expand their customer bases, boost sales, and increase revenue. A clinical trial monitoring solution is a comprehensive system or set of tools designed to oversee and manage various aspects of clinical trials. For example, in April 2022, Tata Consultancy Services (TCS), an India-based information technology (IT) services and consulting company, introduced a Risk-Based Monitoring solution. This innovative solution utilizes advanced statistical algorithms to proactively identify and address study and site risks in biopharmaceutical and Contract Research Organizations (CROs). Using data science, the solution accurately predicts outcomes related to site workload and risks, enabling stakeholders to implement informed monitoring strategies. The Risk-Based Monitoring solution provides unprecedented insights into missing data, enhancing data quality, consistency, and early detection of trends. With the potential for up to a 30% efficiency gain in site monitoring, the solution's automation streamlines processes, reduces site workload, ensures compliance, and accelerates product speed-to-market.

In July 2021, ICON PLC, an Ireland-based clinical research organization, completed the acquisition of PRA Health Sciences for $12 billion. Through this acquisition, ICON plc aimed to enhance operations to transform clinical trials and expedite the commercial success of biopharma clients in developing essential pharmaceuticals and medical devices. Additionally, the acquisition allowed ICON plc to focus on leveraging data, utilizing technology, and reaching diverse patient populations to expedite the development of new drugs. PRA Health Sciences Inc. is a US-based contract research organization (CRO) that offers data solutions and outsourced clinical development services.

Major companies operating in the healthcare cro services market report are Laboratory Corporation of America Holdings., IQVIA Inc., Icon Plc., PPD Inc., Wuxi Apptec Co. Ltd., Syneos Health Inc., Parexel International Corporation, Charles River Laboratories International Inc., Covance Inc., Medpace Inc., Pharmaron Beijing Co. Ltd., BioClinica Inc., Chiltern International Ltd., Evotec SE, PSI CRO AG, Premier Research Group Ltd., Worldwide Clinical Trials Inc., Caidya, BioTelemetry Inc., Syngene International Limited, Novotech CRO, Celerion, GVK Biosciences Private Limited, Synteract Inc., Veristat LLC., ACM Global Laboratories, ClinTec Luxembourg SA, Clinlogix LLC

North America was the largest region in the healthcare CRO services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare cro services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the healthcare cro services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The healthcare CRO services market includes revenues earned by entities by providing services such as discovery studies, pre-clinical services, analytical testing, and related pharmacovigilance and drug safety, data management, and biostatistics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare CRO Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare cro services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare cro services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The healthcare cro services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Service Type: Early Phase Development; Clinical Development Services; Laboratory Services; Consulting Services
  • 2) By Therapeutic Area: Oncology; CNS Disorder; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Diabetes; Other Therapeutic Areas
  • 3) By End User: Pharmaceutical Companies; Medical Device Companies; Academic Institutes
  • Companies Mentioned: Laboratory Corporation of America Holdings.; IQVIA Inc.; Icon Plc.; PPD Inc.; Wuxi Apptec Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare CRO Services Market Characteristics

3. Healthcare CRO Services Market Trends And Strategies

4. Healthcare CRO Services Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Healthcare CRO Services Market Size and Growth

  • 5.1. Global Healthcare CRO Services Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Healthcare CRO Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Healthcare CRO Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Healthcare CRO Services Market Segmentation

  • 6.1. Global Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Early Phase Development
  • Clinical Development Services
  • Laboratory Services
  • Consulting Services
  • 6.2. Global Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Metabolic Disease
  • Infectious Disease
  • Diabetes
  • Other Therapeutic Areas
  • 6.3. Global Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes

7. Healthcare CRO Services Market Regional And Country Analysis

  • 7.1. Global Healthcare CRO Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Healthcare CRO Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Healthcare CRO Services Market

  • 8.1. Asia-Pacific Healthcare CRO Services Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Healthcare CRO Services Market

  • 9.1. China Healthcare CRO Services Market Overview
  • 9.2. China Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Healthcare CRO Services Market

  • 10.1. India Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Healthcare CRO Services Market

  • 11.1. Japan Healthcare CRO Services Market Overview
  • 11.2. Japan Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Healthcare CRO Services Market

  • 12.1. Australia Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Healthcare CRO Services Market

  • 13.1. Indonesia Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Healthcare CRO Services Market

  • 14.1. South Korea Healthcare CRO Services Market Overview
  • 14.2. South Korea Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Healthcare CRO Services Market

  • 15.1. Western Europe Healthcare CRO Services Market Overview
  • 15.2. Western Europe Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Healthcare CRO Services Market

  • 16.1. UK Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Healthcare CRO Services Market

  • 17.1. Germany Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Healthcare CRO Services Market

  • 18.1. France Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Healthcare CRO Services Market

  • 19.1. Italy Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Healthcare CRO Services Market

  • 20.1. Spain Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Healthcare CRO Services Market

  • 21.1. Eastern Europe Healthcare CRO Services Market Overview
  • 21.2. Eastern Europe Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Healthcare CRO Services Market

  • 22.1. Russia Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Healthcare CRO Services Market

  • 23.1. North America Healthcare CRO Services Market Overview
  • 23.2. North America Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Healthcare CRO Services Market

  • 24.1. USA Healthcare CRO Services Market Overview
  • 24.2. USA Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Healthcare CRO Services Market

  • 25.1. Canada Healthcare CRO Services Market Overview
  • 25.2. Canada Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Healthcare CRO Services Market

  • 26.1. South America Healthcare CRO Services Market Overview
  • 26.2. South America Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Healthcare CRO Services Market

  • 27.1. Brazil Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Healthcare CRO Services Market

  • 28.1. Middle East Healthcare CRO Services Market Overview
  • 28.2. Middle East Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Healthcare CRO Services Market

  • 29.1. Africa Healthcare CRO Services Market Overview
  • 29.2. Africa Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Healthcare CRO Services Market Competitive Landscape And Company Profiles

  • 30.1. Healthcare CRO Services Market Competitive Landscape
  • 30.2. Healthcare CRO Services Market Company Profiles
    • 30.2.1. Laboratory Corporation of America Holdings.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. IQVIA Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Icon Plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. PPD Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Wuxi Apptec Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Healthcare CRO Services Market Other Major And Innovative Companies

  • 31.1. Syneos Health Inc.
  • 31.2. Parexel International Corporation
  • 31.3. Charles River Laboratories International Inc.
  • 31.4. Covance Inc.
  • 31.5. Medpace Inc.
  • 31.6. Pharmaron Beijing Co. Ltd.
  • 31.7. BioClinica Inc.
  • 31.8. Chiltern International Ltd.
  • 31.9. Evotec SE
  • 31.10. PSI CRO AG
  • 31.11. Premier Research Group Ltd.
  • 31.12. Worldwide Clinical Trials Inc.
  • 31.13. Caidya
  • 31.14. BioTelemetry Inc.
  • 31.15. Syngene International Limited

32. Global Healthcare CRO Services Market Competitive Benchmarking

33. Global Healthcare CRO Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Healthcare CRO Services Market

35. Healthcare CRO Services Market Future Outlook and Potential Analysis

  • 35.1 Healthcare CRO Services Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Healthcare CRO Services Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Healthcare CRO Services Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer